Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA12 | O43570 | 5/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1035915 | 0.81 | CA1 (0.43) | TDP1CA1CA12CA9TP53 | |
| SCHEMBL27564460 | 0.79 | CA1 (0.42) | TDP1CA1CA12CA9TP53 | |
| Hydrochloric Acid SCHEMBL10538290 | 0.79 | CA1 (0.42) | TDP1CA1CA12CA9TP53 | |
| SCHEMBL241253 | 0.77 | MEN1 (0.40) | TDP1CA1CA12CA9TP53 | |
| SCHEMBL11464417 | 0.77 | CA1 (0.38) | TDP1CA1CA12CA9TP53 | |
| SCHEMBL5959118 | 0.76 | CA5A (0.36) | TDP1CA1CA9CA2CA7 | |
| Sulfuric Acid SCHEMBL27883459 | 0.76 | CA1 (0.46) | TDP1CA1CA12CA9TP53 | |
| Sulfuric Acid SCHEMBL2148402 | 0.76 | CA1 (0.46) | TDP1CA1CA12CA9TP53 | |
| Sulfuric Acid SCHEMBL5874269 | 0.76 | CA1 (0.46) | TDP1CA1CA12CA9TP53 | |
| SCHEMBL17545124 | 0.76 | TDP1 (0.47) | TDP1CA1CA12CA9SERPINE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030095924-A1 | Galenical formulations | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095924-A1 | Galenical formulations | GALR1, GALR2, LGALS1 | TDP1 2074/4885CA1 1901/4885CA12 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.